Sepideh Gholami

9PUBLICATIONS
63CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 16, 2025
Clinical Utility and Prognostic Implications of Circulating Cell-Free DNA in Biliary Tract Cancer.

Darren Cowzer, Madison Darmofal, Kenneth Seier

|Jul 12, 2025
The Role of KRAS Status Among Patients Undergoing Staged Versus Simultaneous Resection for Synchronous Colorectal Liver Metastases.

Andrea Baldo, Odysseas P Chatzipanagiotou, Jun Kawashima

|Jun 12, 2025
Liver-Directed Therapies in Colorectal Cancer: Old Hats and New Tricks.

Nicholas Hornstein, Jacob Levenson, Toshihiro Nakayama

|Jan 06, 2025
Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients With RAS/BRAF Wild-Type, HER2-Positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase II Trial.

Kanwal Pratap Singh Raghav, Katherine A Guthrie, Benjamin Tan

|Aug 08, 2024
Management of Locally Advanced Rectal Cancer: ASCO Guideline.

Aaron J Scott, Erin B Kennedy, Jordan Berlin

|Aug 23, 2023
Disparities in treatment and survival in early-stage hepatocellular carcinoma in California.

Sepideh Gholami, Kara T Kleber, Lauren M Perry

Pageof 2